Vitrolife AB logo

VITR - Vitrolife AB News Story

SEK245 2.8  1.2%

Last Trade - 8:22am

Sector
Healthcare
Size
Mid Cap
Market Cap £2.32bn
Enterprise Value £2.26bn
Revenue £117.4m
Position in Universe 183rd / 1787

BRIEF-Vitrolife Updates On Impact Of COVID-19 On Co's Sales

Wed 3rd June, 2020 7:42am
June 3 (Reuters) - Vitrolife AB  VITR.ST :
    * UPDATE ON THE IMPACT OF COVID-19 ON VITROLIFE'S SALES
    * VITROLIFE ESTIMATES THAT SALES IN Q2 WILL AMOUNT TO ABOUT
40-50%
OF CORRESPONDING PERIOD LAST YEAR IN LOCAL CURRENCY AND THAT
SALES RECOVERY WILL CONTINUE DURING REST OF YEAR
    * ESTIMATES THAT VAST MAJORITY OF PATIENTS THAT NOW POSTPONE
IVF
TREATMENTS WILL COMPLETE THESE AT A LATER DATE
    * ESTIMATES THAT LONG-TERM MARKET OUTLOOK IS ESSENTIALLY
UNCHANGED
AND VITROLIFE THEREFORE EXPECTS A CONTINUOUSLY EXPANDING MARKET,
WHICH IN MONETARY TERMS IS EXPECTED TO GROW BY 5-10 PER CENT PER
YEAR FOR FORESEEABLE FUTURE

Source text for Eikon:  ID:nWkr2N4Ztn 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.